Cadila Pharma unveils three-dose rabies vaccine ThRabis

Pharmaceutical major Cadila Pharmaceuticals on Friday announced that it has developed the world's first novel three-dose vaccine against rabies.

The three-dose vaccine, named as 'ThRabis', is a recombinant nano-particle based G protein vaccine which is prepared using Virus-like Particle technology, the company said in a release, adding that the three-dose schedule is spread over only one week.

For more information, check out the full story on the link below:  

FIRST: Cadila Pharma Launches Three-Dose Rabies Vaccine ThRabis